Document Type
Study Protocol
Title

CSER Phase 1: Personalized Oncology Through High-throughput Sequencing: MI-ONCOSEQ Study Protocol

Author(s):

Author Name(s)
Talpaz, Moshe
Chinnaiyan, Arul M.

Year:

Year
2015

The Personalized Oncology Through High-throughput Sequencing: MI-ONCOSEQ (Michigan Oncology Sequencing Center) (formerly known as “Personalized Medicine Based on Molecular Profiling of Patients with Cancer”) study implements a mechanism for patients who have advanced or refractory cancer to undergo tumor sequencing, sequence analysis, and return of clinically significant sequence results to patients, their families and the clinicians. This document is the revised study protocol. It contains 5 appendices: 1. Study Calendar; 2. Sample Molecular Report; 3. Adverse Event Reporting Form; 4. Genes Queried; 5. Genetic Information Nondiscrimination Act.

Research Population:

Research Population
Adults

Share